Mammalian cells acquire epigenetic hallmarks of human cancer during immortalization.
Mammalian cells acquire epigenetic hallmarks of human cancer during immortalization.
复制标题
DOI:
10.1093/nar/gks1051
复制
发表时间:
2013-01-07
影响因子:
14.9
通讯作者:
Besaratinia A
中科院分区:
文献类型:
--
作者:
Tommasi S;Zheng A;Weninger A;Bates SE;Li XA;Wu X;Hollstein M;Besaratinia A
Progression to malignancy requires that cells overcome senescence and switch to an immortal phenotype. Thus, exploring the genetic and epigenetic changes that occur during senescence/immortalization may help elucidate crucial events that lead to cell transformation. In the present study, we have globally profiled DNA methylation in relation to gene expression in primary, senescent and immortalized mouse embryonic fibroblasts. Using a high-resolution genome-wide mapping technique, followed by extensive locus-specific validation assays, we have identified 24 CpG islands that display significantly higher levels of CpG methylation in immortalized cell lines as compared to primary murine fibroblasts. Several of these hypermethylated CpG islands are associated with genes involved in the MEK–ERK pathway, one of the most frequently disrupted pathways in cancer. Approximately half of the hypermethylated targets are developmental regulators, and bind to the repressive Polycomb group (PcG) proteins, often in the context of bivalent chromatin in mouse embryonic stem cells. Because PcG-associated aberrant DNA methylation is a hallmark of several human malignancies, our methylation data suggest that epigenetic reprogramming of pluripotency genes may initiate cell immortalization. Consistent with methylome alterations, global gene expression analysis reveals that the vast majority of genes dysregulated during cell immortalization belongs to gene families that converge into the MEK–ERK pathway. Additionally, several dysregulated members of the MAP kinase network show concomitant hypermethylation of CpG islands. Unlocking alternative epigenetic routes for cell immortalization will be paramount for understanding crucial events leading to cell transformation. Unlike genetic alterations, epigenetic changes are reversible events, and as such, can be amenable to pharmacological interventions, which makes them appealing targets for cancer therapy when genetic approaches prove inadequate.
登录
查看更多内容
影响因子:
78.5
作者:
Collado, Manuel;Serrano, Manuel
通讯作者:
Serrano, Manuel
影响因子:
3.7
作者:
Coppé JP;Patil CK;Rodier F;Krtolica A;Beauséjour CM;Parrinello S;Hodgson JG;Chin K;Desprez PY;Campisi J
通讯作者:
Campisi J
DOI:
10.1146/annurev-pathol-121808-102144
发表时间:
2010
期刊:
Annual review of pathology
影响因子:
--
作者:
Coppé JP;Desprez PY;Krtolica A;Campisi J
通讯作者:
Campisi J
DOI:
10.4161/cc.7.17.6522
发表时间:
2008-09-01
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
作者:
Glazer RI;Wang XY;Yuan H;Yin Y
通讯作者:
Yin Y
影响因子:
4.3
作者:
Feng, Lijin;Hollstein, Monica;Xu, Yang
通讯作者:
Xu, Yang